| Literature DB >> 30041694 |
Sarah A Vermillion1, Alston James1, Robert D Dorrell1, Peter Brubaker2, Shannon L Mihalko2, Adrienne R Hill3, Clancy J Clark4.
Abstract
BACKGROUND: Gastrointestinal cancer patients are susceptible to significant postoperative morbidity. The aim of this systematic review was to examine the effects of preoperative exercise therapy (PET) on patients undergoing surgery for GI malignancies.Entities:
Keywords: Cancer; Exercise therapy; Preoperative; Surgery
Mesh:
Year: 2018 PMID: 30041694 PMCID: PMC6058356 DOI: 10.1186/s13643-018-0771-0
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Fig. 1Study selection flow diagram
Fig. 2Risk of bias summary based on Cochrane Risk of Bias Tool [22]
Fig. 3Risk of bias graph based on Cochrane Risk of Bias Tool [22]
Summary of patient characteristics
| Study | Patient population | Groups |
| Age (year) | % male | ASA > II | BMI (kg/m2) |
|---|---|---|---|---|---|---|---|
| Carli et al. | Benign or malignant colorectal cancer | Intervention | 58 | 61 ± 16 | 59 | 22% | 28 ± 6 |
| Control | 54 | 60 ± 15 | 57 | 20% | 27 ± 5 | ||
| Cho et al. | Gastric cancer | Intervention | 18 | 63.1 (51–76)* | 100 | NR | 26.7 (23.1–31.2)* |
| Control | 54 | 66.1 (39–81)* | 94.4 | NR | 25.7 (20.8–34.1)* | ||
| Dronkers et al. | Colon cancer | Intervention | 22 | 71.1 ± 6.3 | 68.2 | NR | 26.6 ± 3.6 |
| Control | 20 | 68.8 ± 6.4 | 80 | NR | 25.6 ± 3.1 | ||
| Gillis et al. | Colorectal cancer | Intervention | 38 | 65.7 ± 13.6 | 55 | 26% | 26.9 ± 4.6 |
| Control | 39 | 66.0 ± 9.1 | 69 | 23% | 28.5 ± 4.3 | ||
| Kaibori et al. | Hepatocellular carcinoma | Intervention | 25 | 68 ± 9.1 | 68 | NR | NR |
| Control | 26 | 71.3 ± 8.8 | 73 | NR | NR | ||
| Kim et al. | Benign or malignant colorectal cancer | Intervention | 14 | 55 ± 15 | 64 | NR | 26.6 ± 5.9 |
| Control | 7 | 65 ± 9 | 57 | NR | 25.3 ± 2.7 | ||
| Li et al. | Colorectal cancer | Intervention | 42 | 67.4 ± 11 | 54 | 19% | 27.5 ± 4 |
| Control | 45 | 66.4 ± 12 | 64 | 22% | 26.9 ± 6 | ||
| West et al. | Rectal cancer treated with NACRT | Intervention | 22 | 64 (45–82)* | 64 | 9% | NR |
| Control | 13 | 72 (62–84) | 69 | 15% | NR | ||
| Dunne et al. | Colorectal liver metastasis | Intervention | 20 | 61 (56–66)* | 65 | NR | 29.2 ± 4.1 |
| Control | 17 | 62 (53–72)* | 77 | NR | 29.3 ± 4.2 |
Age and BMI values are presented as mean ± standard deviation, unless otherwise noted
*Range reported, rather than standard deviation
NACRT neoadjuvant chemoradiotherapy, NR not reported, BMI body mass index, ASA American Society of Anesthesiologist class
Summary of preoperative exercise therapy regimens
| Study | Groups | Length of therapy | Frequency | Duration | Intensity | Follow-up | Outcome |
|---|---|---|---|---|---|---|---|
| Carli et al. | Biking/strengthening | 59.0 days* | Daily | 20–45 min | ≥ 50% MHR. Volitional fatigue within 8–12 repetitions. | 2–4 m | ↔Functional walking capacity before surgery |
| Walk/breathing | 45.4 days* | Daily | 40–45 min | 2–4 m | |||
| Cho et al. | Aerobic/resistance training, stretching | 4 weeks | 3–7/week | NR | NR | 1 year | ↓ BMI, Body weight, abdominal circumference, volume of visceral fat |
| Matched controls in database | NA | NA | NA | NA | NA | ||
| Dronkers et al. | Aerobic exercise, resistance training, IMT | 2–4 weeks | Daily | 30–60 min | 55–75% MHR, 11–13 on Borg Scale | NR | ↑ Respiratory muscle endurance in preoperative period |
| Home-based exercise advice | 2–4 weeks | Daily | ≥ 30 mins | NR | NR | ||
| Gillis et al. | Aerobic/resistance training, nutritional therapy, relaxation exercises before and after surgery | 4 weeks pre-op, 8 weeks post-op | ≥ 3/week | 50 mins | ≥ 40% HRR, 8–12 repetitions | 8 weeks | ↑ Functional walking capacity before surgery, and at 8 weeks post-op |
| Aerobic/resistance training, nutritional therapy, relaxation exercises after surgery | 8 weeks post-op | ≥ 3/week | 50 mins | ≥ 40% HRR, 8–12 repetitions | 8 weeks | ||
| Kaibori et al. | Aerobic exercise, diet therapy | ≤ 1 month pre-op, 6 months post-op | 3/week | 60 mins | NR | 6 m | ↓Body mass, fat mass |
| Diet therapy | ≤ 1 month pre-op, 6 months post-op | NA | NA | NA | 6 m | ||
| Kim et al. | Aerobic exercise | 4 weeks | Daily | 20–30 min | 40–65% HRR | 4 weeks | ↓Heart rate, oxygen consumption |
| Standard care | NA | NA | NA | NA | 4 weeks | ||
| Li et al. | Aerobic/resistance training, diet therapy, relaxation exercises | 21–46 days | 3/week | 30 mins | 50% MHR; volitional fatigue | 8 weeks | ↑Functional walking capacity at 4 weeks and 8 weeks postoperatively |
| Standard care | NA | NA | NA | NA | 8 weeks | ||
| West et al. | Aerobic exercise | 6 weeks | 3/week | 40 mins | Intervals at 80% pVO2 work rate at θL and 50% of the difference between in work rates between pVO2 and VO2 at θL | 6 weeks | ↓ VO2 at θL after NACRT |
| Dunne et al. | Aerobic exercise | 4 weeks | 12 sessions | 30 mins | Interval training alternating at less than 60% pVO2 at peak and more than 90% pVO2 at peak | 4 weeks | ↑ VO2 at AT and peak after exercise |
| Standard care | NA | NA | NA | NA | 4 weeks | ||
Length of therapy refers to therapy prior to surgery, unless otherwise noted
*Mean: ↑ = statistically significant increase compared with control group, ↓ = statistically significant decrease compared with control group, ↔ = no significant difference between groups
AT anabolic threshold, HRR heart rate reserve, IMT inspiratory muscle training, MHR maximal heart rate, NACRT neoadjuvant chemoradiotherapy, NA not applicable, NR not reported, QOL quality of life, VO oxygen uptake, θ lactate threshold